[go: up one dir, main page]

HK1252755A1 - 工程化靶向核酸的核酸 - Google Patents

工程化靶向核酸的核酸

Info

Publication number
HK1252755A1
HK1252755A1 HK18112080.6A HK18112080A HK1252755A1 HK 1252755 A1 HK1252755 A1 HK 1252755A1 HK 18112080 A HK18112080 A HK 18112080A HK 1252755 A1 HK1252755 A1 HK 1252755A1
Authority
HK
Hong Kong
Prior art keywords
nucleic
acid targeting
engineered
nucleic acids
acids
Prior art date
Application number
HK18112080.6A
Other languages
English (en)
Other versions
HK1252755B (zh
Inventor
Paul Daniel Donohoue
Andrew Paul May
Original Assignee
Caribou Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caribou Biosciences Inc filed Critical Caribou Biosciences Inc
Publication of HK1252755A1 publication Critical patent/HK1252755A1/zh
Publication of HK1252755B publication Critical patent/HK1252755B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/51Physical structure in polymeric form, e.g. multimers, concatemers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/52Physical structure branched
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18112080.6A 2015-12-04 2018-09-19 工程化靶向核酸的核酸 HK1252755B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562263232P 2015-12-04 2015-12-04
PCT/US2016/064860 WO2017096328A1 (en) 2015-12-04 2016-12-02 Engineered nucleic-acid targeting nucleic acids

Publications (2)

Publication Number Publication Date
HK1252755A1 true HK1252755A1 (zh) 2019-05-31
HK1252755B HK1252755B (zh) 2020-02-07

Family

ID=57750577

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112080.6A HK1252755B (zh) 2015-12-04 2018-09-19 工程化靶向核酸的核酸

Country Status (18)

Country Link
US (4) US9771600B2 (zh)
EP (2) EP3564371B1 (zh)
JP (1) JP6707133B2 (zh)
KR (1) KR102093570B1 (zh)
CN (1) CN108473981B (zh)
AU (2) AU2016363024B2 (zh)
BR (1) BR112018010429A2 (zh)
CA (1) CA3004757C (zh)
DK (1) DK3371310T3 (zh)
ES (1) ES2735773T3 (zh)
HK (1) HK1252755B (zh)
IL (1) IL259148B (zh)
MX (1) MX2018005392A (zh)
NZ (2) NZ756843A (zh)
RU (1) RU2018117360A (zh)
SG (1) SG11201803593QA (zh)
WO (1) WO2017096328A1 (zh)
ZA (1) ZA201802968B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6707133B2 (ja) 2015-12-04 2020-06-10 カリブー・バイオサイエンシーズ・インコーポレイテッド 操作された核酸標的化核酸
US10266851B2 (en) * 2016-06-02 2019-04-23 Sigma-Aldrich Co. Llc Using programmable DNA binding proteins to enhance targeted genome modification
US11499151B2 (en) 2017-04-28 2022-11-15 Editas Medicine, Inc. Methods and systems for analyzing guide RNA molecules
US11584955B2 (en) * 2017-07-14 2023-02-21 Shanghai Tolo Biotechnology Company Limited Application of Cas protein, method for detecting target nucleic acid molecule and kit
CN107488710B (zh) 2017-07-14 2020-09-22 上海吐露港生物科技有限公司 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
WO2019041296A1 (zh) * 2017-09-01 2019-03-07 上海科技大学 一种碱基编辑系统及方法
JP2020537498A (ja) * 2017-09-11 2020-12-24 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 哺乳類細胞へのcas9の抗体媒介性送達
US20210093679A1 (en) 2018-02-05 2021-04-01 Novome Biotechnologies, Inc. Engineered gut microbes and uses thereof
JP2021512617A (ja) 2018-02-08 2021-05-20 ザイマージェン インコーポレイテッド CorynebacteriumにおいてCRISPRを使用するゲノム編集
CN112654710A (zh) 2018-05-16 2021-04-13 辛瑟高公司 用于指导rna设计和使用的方法和系统
BR112021002476A2 (pt) * 2018-08-09 2021-07-27 G+Flas Life Sciences nova proteína associada a crispr e uso da mesma
CN109517722B (zh) * 2018-09-28 2022-04-01 德拜至臻医学科技(杭州)有限公司 一种捕获特定微量细胞的装置及其制作和使用方法
JP2022520139A (ja) 2018-10-12 2022-03-29 セラダプティブ インク β-リン酸三カルシウム結合配列を含むポリペプチドとその使用
US20220290120A1 (en) 2019-02-25 2022-09-15 Novome Biotechnologies, Inc. Plasmids for gene editing
CN114901302A (zh) * 2019-11-05 2022-08-12 成对植物服务股份有限公司 Rna编码的dna置换等位基因的组合物和方法
WO2021194604A2 (en) * 2020-03-06 2021-09-30 Theradaptive, Inc. Therapeutic compositions comprising graft materials and beta-tcp binding peptides and uses thereof
US11639523B2 (en) * 2020-03-23 2023-05-02 The Broad Institute, Inc. Type V CRISPR-Cas systems and use thereof
JP2024520528A (ja) 2021-06-01 2024-05-24 アーバー バイオテクノロジーズ, インコーポレイテッド Crisprヌクレアーゼを含む遺伝子編集システム及びそれらの使用
CN114540325B (zh) * 2022-01-17 2022-12-09 广州医科大学 靶向dna去甲基化的方法、融合蛋白及其应用
CN116377104B (zh) * 2022-11-14 2024-01-12 海南省农业科学院蔬菜研究所 一种快菜高温胁迫内参基因及其引物及应用
TW202440938A (zh) 2023-02-15 2024-10-16 美商喬木生物技術公司 用於抑制微管解聚蛋白2(stmn2)轉錄物中異常剪接的基因編輯方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10087431B2 (en) 2010-03-10 2018-10-02 The Regents Of The University Of California Methods of generating nucleic acid fragments
EP2569425B1 (en) 2010-05-10 2016-07-06 The Regents of The University of California Endoribonuclease compositions and methods of use thereof
JP2014529463A (ja) * 2011-09-01 2014-11-13 ヒップ・イノベーション・テクノロジー・エルエルシー ライナを付けられた大腿骨カップ
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
LT2800811T (lt) 2012-05-25 2017-09-11 The Regents Of The University Of California Būdai ir kompozicijos, skirti tikslinės dnr modifikavimui, panaudojant adresuotą rnr, ir transkripcijos moduliavimui, panaudojant adresuotą rnr
WO2013188638A2 (en) 2012-06-15 2013-12-19 The Regents Of The University Of California Endoribonucleases and methods of use thereof
WO2014022702A2 (en) 2012-08-03 2014-02-06 The Regents Of The University Of California Methods and compositions for controlling gene expression by rna processing
CN110669758A (zh) 2012-10-23 2020-01-10 基因工具股份有限公司 用于切割靶dna 的组合物及其用途
WO2014093694A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
US20140189896A1 (en) 2012-12-12 2014-07-03 Feng Zhang Crispr-cas component systems, methods and compositions for sequence manipulation
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
ES2786193T3 (es) 2012-12-12 2020-10-09 Broad Inst Inc Modificación por tecnología genética y optimización de sistemas, métodos y composiciones enzimáticas mejorados para la manipulación de secuencias
ES2542015T3 (es) 2012-12-12 2015-07-29 The Broad Institute, Inc. Ingeniería de sistemas, métodos y composiciones de guía optimizadas para manipulación de secuencias
EP3620534B1 (en) 2013-03-14 2021-10-13 Caribou Biosciences, Inc. Crispr-cas compositions of nucleic acid-targeting nucleic acids
EP3375877A1 (en) 2013-11-18 2018-09-19 Crispr Therapeutics AG Crispr-cas system materials and methods
WO2015089364A1 (en) * 2013-12-12 2015-06-18 The Broad Institute Inc. Crystal structure of a crispr-cas system, and uses thereof
US20150376586A1 (en) 2014-06-25 2015-12-31 Caribou Biosciences, Inc. RNA Modification to Engineer Cas9 Activity
IL288263B (en) * 2015-01-28 2022-07-01 Caribou Biosciences Inc Crispr hybrid dna/rna polynucleotides and methods of use
US9580727B1 (en) * 2015-08-07 2017-02-28 Caribou Biosciences, Inc. Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
JP6707133B2 (ja) * 2015-12-04 2020-06-10 カリブー・バイオサイエンシーズ・インコーポレイテッド 操作された核酸標的化核酸

Also Published As

Publication number Publication date
EP3564371A1 (en) 2019-11-06
US10100333B2 (en) 2018-10-16
US20180251788A1 (en) 2018-09-06
SG11201803593QA (en) 2018-06-28
ZA201802968B (en) 2019-02-27
DK3371310T3 (da) 2019-08-05
EP3371310A1 (en) 2018-09-12
US20190100775A1 (en) 2019-04-04
CA3004757C (en) 2020-07-21
JP2019500867A (ja) 2019-01-17
KR102093570B1 (ko) 2020-03-25
IL259148B (en) 2021-08-31
EP3371310B1 (en) 2019-05-01
AU2019240724B2 (en) 2021-02-18
MX2018005392A (es) 2019-05-30
AU2016363024B2 (en) 2020-01-30
US9970029B1 (en) 2018-05-15
JP6707133B2 (ja) 2020-06-10
NZ756843A (en) 2021-07-30
US9771600B2 (en) 2017-09-26
KR20180085795A (ko) 2018-07-27
RU2018117360A (ru) 2020-01-09
CA3004757A1 (en) 2017-06-08
NZ742040A (en) 2019-08-30
CN108473981B (zh) 2022-04-12
US20180119173A1 (en) 2018-05-03
HK1252755B (zh) 2020-02-07
CN108473981A (zh) 2018-08-31
ES2735773T3 (es) 2019-12-20
US20170159073A1 (en) 2017-06-08
AU2019240724A1 (en) 2019-10-24
WO2017096328A1 (en) 2017-06-08
BR112018010429A2 (pt) 2018-11-27
US11505808B2 (en) 2022-11-22
AU2016363024A1 (en) 2018-05-17
RU2018117360A3 (zh) 2020-01-09
EP3564371B1 (en) 2020-05-27
IL259148A (en) 2018-07-31

Similar Documents

Publication Publication Date Title
HK1252755B (zh) 工程化靶向核酸的核酸
ZA201905396B (en) Trans-replicating rna
HK1248284A1 (zh) 多重乳液核酸擴增
HRP20190235T1 (hr) Antisensna nukleinska kiselina
ZA201700142B (en) Antisense nucleic acids
IL254000B (en) Nucleic acid sequence composition
IL258065B (en) Nucleic acids against the coding strand
GB201507119D0 (en) Nucleic Acid Construct
GB201507115D0 (en) Nucleic Acid Construct
GB201507111D0 (en) Nucleic acid construct
GB201507108D0 (en) Nucleic acid construct
GB201507104D0 (en) Nucleic acid construct
IL257831A (en) Diplospore garden
HK1250682A1 (zh) 核酸擴增
IL257500A (en) Altered cullin1 gene
GB201517241D0 (en) DNA modification
GB201409709D0 (en) Improved deoxyribonuclease enzymes
GB201402630D0 (en) Nucleic acid amplification